6 States Join FTC's Challenge To Amgen's $28B Horizon Buy
Illinois and California are among six states that have joined the Federal Trade Commission's antitrust suit against Amgen's planned $28 billion purchase of Horizon Therapeutics, the maker of the drug Tepezza...To view the full article, register now.
Already a subscriber? Click here to view full article